L. Kay

Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).

H. Brewer, E. Schaefer, L. Kay, 1982, The Journal of clinical investigation.

Tangier disease : A structural defect in apolipoprotein A-I ( apoA-ITangir ) ( apolipoprotein A-1 H / dyslipoproteinemia / atherosclerosis / high density lipoproteins / cholesterol )

H. Brewer, E. Schaefer, L. Kay, 2003 .

Human proapoA-ITangier: isolation of proapoA-ITangier and amino acid sequence of the propeptide.

H. Brewer, L. Kay, R. Ronan, 1983, Biochemical and biophysical research communications.

Human plasma proapoA-I: isolation and amino-terminal sequence.

H. Brewer, L. Kay, R. Ronan, 1983, Biochemical and biophysical research communications.

Purification and characterization of apolipoprotein C-II from human plasma by high-pressure liquid chromatography.

H. Brewer, L. Kay, R. Ronan, 1982, Biochimica et biophysica acta.